Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma

NCT01968928 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT01968928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01968928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2014
Completion date
December 31, 2016
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder urothelial carcinoma